Nuwellis, Inc. (NUWE)

NASDAQ: NUWE · Real-Time Price · USD
14.80
-0.96 (-6.09%)
At close: Jul 18, 2025, 4:00 PM
14.95
+0.15 (1.01%)
After-hours: Jul 18, 2025, 6:29 PM EDT
-6.09%
Market Cap1.68M
Revenue (ttm)8.79M
Net Income (ttm)-9.85M
Shares Out 113.83K
EPS (ttm)-174.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume173,042
Open15.25
Previous Close15.76
Day's Range14.31 - 16.50
52-Week Range6.33 - 178.50
Beta0.28
AnalystsStrong Buy
Price Target714.00 (+4,724.32%)
Earnings DateAug 12, 2025

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Aust... [Read more]

Sector Healthcare
Founded 1999
Employees 38
Stock Exchange NASDAQ
Ticker Symbol NUWE
Full Company Profile

Financial Performance

In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.

Financial Statements

Analyst Summary

According to one analyst, the rating for NUWE stock is "Strong Buy" and the 12-month stock price target is $714.0.

Price Target
$714.0
(4,724.32% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

WHO WHAT WHEN WHY Nuwellis, Inc. Termination of theREVERSE-HF clinicaltrial July 17, 2025 To redirect resources towardoutpatient markets where scalableimpact is highest.   MINNEAPOLIS, July 17, 2025 (...

1 day ago - GlobeNewsWire

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

WHO WHAT WHERE WHEN WHY Nuwellis, Inc. Issuance of U.S. Patent No. 12,357,734 United States Patent and Trademark Office July 15, 2025 To protect innovations in blood filtering system design and method...

3 days ago - GlobeNewsWire

Nuwellis Appoints John Erb as Chief Executive Officer

WHO WHAT WHERE WHEN HOW John Erb Appointed as Chief Executive Officer (no longer serving in an interim capacity) Nuwellis Headquarters Effective June 27, 2025 Appointment confirmed by the Board of Dir...

16 days ago - GlobeNewsWire

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload ...

5 weeks ago - GlobeNewsWire

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload ...

5 weeks ago - GlobeNewsWire

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2025 Earnings Conference Call May 13, 2025 9:00 AM ET Company Participants Louisa Smith - IR, Gilmartin Group John Erb - Chairman & Interim CEO Rob Scott - CFO Confere...

2 months ago - Seeking Alpha

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced finan...

2 months ago - GlobeNewsWire

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Strategic agreement is expected to reduce costs, preserve expertise, and streamline operations. WHO WHAT WHERE WHEN WHY Nuwellis, Inc. (Nasdaq: NUWE) and KDI Precision Manufacturing Outsourcing manufa...

2 months ago - GlobeNewsWire

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

MINNEAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced a mean...

2 months ago - GlobeNewsWire

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced the ...

3 months ago - GlobeNewsWire

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

MINNEAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today anno...

3 months ago - GlobeNewsWire

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2024 Earnings Conference Call March 11, 2025 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations John Erb - Interim President and Ch...

4 months ago - Seeking Alpha

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported...

4 months ago - GlobeNewsWire

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

John Erb, Current Chair of the Board, Appointed Interim President and CEO John Erb, Current Chair of the Board, Appointed Interim President and CEO

5 months ago - GlobeNewsWire

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

MINNEAPOLIS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today highlight...

5 months ago - GlobeNewsWire

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today annou...

5 months ago - GlobeNewsWire

Nuwellis Regains Compliance with Nasdaq Listing Requirements

MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market ...

7 months ago - GlobeNewsWire

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE) Q3 2024 Earnings Call Transcript November 11, 2024 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President and CEO John Jefferies - CMO Rob Sco...

8 months ago - Seeking Alpha

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results...

8 months ago - GlobeNewsWire

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with...

9 months ago - GlobeNewsWire

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Reimbursement rate to increase 397% per day effective January 1, 2025 New rate expected to encourage adoption of ultrafiltration therapy in the outpatient setting MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEW...

9 months ago - GlobeNewsWire

Nuwellis Announces Preliminary Results for Third Quarter of 2024

MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to transforming the lives of patients suffering from fluid overload, today announced ce...

9 months ago - GlobeNewsWire

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce t...

9 months ago - GlobeNewsWire

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

MINNEAPOLIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will...

9 months ago - GlobeNewsWire

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce ...

10 months ago - GlobeNewsWire